Literature DB >> 10524792

Apoptosis of endothelial cell line ECV304 persistently infected with Orientia tsutsugamushi.

M K Kim1, S H Kee, K A Cho, M H Chung, B U Lim, W H Chang, J S Kang.   

Abstract

Endothelial cells are major targets of Orientia tsutsugamushi. To examine the consequences of the infection of endothelial cells with O. tsutsugamushi, we used human endothelial cell line ECV304. Persistent infection was established and infected cultures could be maintained for over seven months without the addition of normal cells. The heavily infected cells became round and floated in the culture medium, harboring large numbers of organisms inside them. Some of the infected ECV304 cells showed features of apoptotic cells, as determined by the terminal deoxytransferase-mediated dUTP nick end-labeling reaction and DNA fragmentation. We also found that O. tsutsugamushi increased transcription of the mRNAs of proinflammatory cytokines such as IL-6 and IL-8. These results show the first evidence of in vitro-persistent infection by O. tsutsugamushi, which may be related to in vivo persistence reported previously.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524792     DOI: 10.1111/j.1348-0421.1999.tb02466.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Expression of chemokine genes in human dermal microvascular endothelial cell lines infected with Orientia tsutsugamushi.

Authors:  N H Cho; S Y Seong; M S Choi; I S Kim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Haemophilus somnus induces apoptosis in bovine endothelial cells in vitro.

Authors:  M J Sylte; L B Corbeil; T J Inzana; C J Czuprynski
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Orientia tsutsugamushi inhibits apoptosis of macrophages by retarding intracellular calcium release.

Authors:  Mee-Kyung Kim; Seung-Yong Seong; Ju-Young Seoh; Tae-Hee Han; Hyeon-Je Song; Ji-Eun Lee; Jung-Hoon Shin; Byung-Uk Lim; Jae-Seung Kang
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 5.  An Update on Host-Pathogen Interplay and Modulation of Immune Responses during Orientia tsutsugamushi Infection.

Authors:  Fabián E Díaz; Katia Abarca; Alexis M Kalergis
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

6.  Persistence of Orientia tsutsugamushi in humans.

Authors:  Moon-Hyun Chung; Jin-Soo Lee; Ji-hyeon Baek; Mijeong Kim; Jae-Seung Kang
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

7.  Improved antibiotic susceptibility test of Orientia tsutsugamushi by flow cytometry using monoclonal antibody.

Authors:  Mi-Jeong Kim; Mee-Kyung Kim; Jae-Seung Kang
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

Review 8.  Scrub Typhus Pathogenesis: Innate Immune Response and Lung Injury During Orientia tsutsugamushi Infection.

Authors:  Brandon Trent; James Fisher; Lynn Soong
Journal:  Front Microbiol       Date:  2019-09-06       Impact factor: 5.640

9.  IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice.

Authors:  Thomas R Shelite; Yuejin Liang; Hui Wang; Nicole L Mendell; Brandon J Trent; Jiaren Sun; Bin Gong; Guang Xu; Haitao Hu; Donald H Bouyer; Lynn Soong
Journal:  PLoS Negl Trop Dis       Date:  2016-03-04

10.  Polarized lung inflammation and Tie2/angiopoietin-mediated endothelial dysfunction during severe Orientia tsutsugamushi infection.

Authors:  Brandon Trent; Yuejin Liang; Yan Xing; Marisol Esqueda; Yang Wei; Nam-Hyuk Cho; Hong-Il Kim; Yeon-Sook Kim; Thomas R Shelite; Jiyang Cai; Jiaren Sun; Donald H Bouyer; Jinjun Liu; Lynn Soong
Journal:  PLoS Negl Trop Dis       Date:  2020-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.